NuVasive Prices $200 Million Convertible Senior Note... ( SAN DIEGO March 4 /- NuVasive Inc...)

NuVasive Prices $200 Million Convertible Senior Notes Due 2013

Date:3/4/2008

SAN DIEGO, March 4 /PRNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced the pricing of $200 million principal amount of 2.25% Convertible Senior Notes due 2013 through an offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. NuVasive has also granted the initial purchasers an option to purchase up to $30 million of additional notes solely to cover over-allotments. The offering is scheduled to close on March 7, 2008, subject to satisfaction of customary closing conditions.

The notes will pay interest semiannually at a rate of 2.25% per annum. The notes will be convertible into shares of NuVasive common stock at a conversion rate of 22.3515 shares of common stock per $1,000 principal amount of notes, which is equal to a conversion price of approximately $44.74 per share.

NuVasive estimates that the net proceeds from the offering will be approximately $193.4 million after deducting the initial purchasers' discounts and commissions and estimated offering expenses, assuming no exercise of the initial purchasers' over-allotment option.

NuVasive intends to use the net proceeds from the offering for general corporate purposes, including potential strategic acquisitions. NuVasive has entered into convertible note hedge transactions with the initial purchasers or their affiliates (the "counterparties") and intends to use a portion of the net proceeds from this offering to pay for the cost of the convertible note hedge transactions. The convertible note hedge transactions are intended to reduce dilution experienced by the company's stockholders upon potential future conversion of the notes. The company has also entered into separate warrant transactions with the counterparties, which would result in additional proceeds to the company, and would partially offset the
'/>"/>

SOURCE NuVasive, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3
Related medicine news :

1. NuVasive to Present at ThinkEquity Partners 5th Annual Growth Conference
2. NuVasive Announces Web Cast and Conference Call of Third Quarter 2007 Results
3. NuVasive Licenses Its Insert and Rotate Technology
4. NuVasive Cancels 10/24/07 Investor Reception Due to Concerns Over Southern California Fires
5. NuVasive to Present at BIOCOM Investor Conference 2007
6. NuVasive Announces Preliminary Unaudited Full Year 2007 Financial Results
7. NuVasive to Offer $200 Million Convertible Senior Notes Due 2013
8. Lincare Holdings Inc. Prices $500 Million Convertible Senior Debentures Offering
9. American Association for Homecare Disputes Validity of Internet Power Wheelchair Prices as Basis for Reimbursement of Services in Medicare
10. Mylan Prices Offerings of Common Stock and Mandatory Convertible Preferred Stock
11. Health care opinion leaders support public reporting of health care quality, prices

Post Your Comments:

(Date:12/1/2009)... , SMITHFIELD, R.I., Dec. 1 /P...equipment, bad assumptions are hazardous and can r... of government regulation, a handful of persistent...h the effectiveness of occupational Hearing Conse..., A new free, white paper from Howard Leight, ...

(Date:12/1/2009)..., WASHINGTON, Dec. 1 ... for International Development: ,, Chairman Ker...ttee. ,, I am honored to be nominated by Presid...States Agency for International Development, and I...y. ,, Secretary of State Clinton has expressed...

(Date:12/1/2009)...lona, 30 November 2009. Performing surgical opera...mera and has become a reality. This is demonstrate... (Natural Orifice Transluminal Endoscopy Surgery),...cal access using the body,s natural orifices. The ... of scars, shorter hospital stay and faster recove...

(Date:12/1/2009)...eal, December 1, 2009 A Universit de Montral rese...enter on Family Violence and Violence Against Wome... of pornography on men. "We started our research s...d pornography. We couldn,t find any," says Simon L...sor at the School of Social Work. , "The object...

(Date:12/1/2009)... Global measles deaths drop worl... (Vocus) December 1, 2009 -- WHAT: Measles Ini...Centers for Disease Control and Prevention, the Un...lth Organization – will announce the latest ...rence on Thursday, December 3, 2009 at 10:00 a.m. ...

[0] New White Paper Details Six Common Bad Assumptions About Hearing Protection [0] Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 [0] Hospital Clinic Barcelona and Massachusetts General Hospital extract rectal mass through anus [0] Are the effects of pornography negligible?[0] **MEDIA ADVISORY** Measles Initiative to Announce Major Achievement in Public Health

...Cogon Systems, Inc.,has completed deployment of th...ida known as the South Florida Health Information ...f of participating providers who undergo a,short t...ENT OF CARE(R) platform, a Microsoft .NET,connecte...

...Best Care Senior,Services has expanded into the Co...n-Home Care, Assisted Living Placement Service, an...seniors in Colorado Springs can now,rely on Always... the betterment of life that goes beyond just doin...

...Jerome ,The Bus, Bettis, NEW YORK, Oct. 31 On Sa...amilies got "into the loop" with the S.L.E. Lupus,...entral Park, presented by,Camp Sunshine and the Ci...00 orange lupus awareness wristbands,saluting Lupu...

... (NYSE:,CNO) today reported results for the third ... number of significant events, as,progress on our ...ty and,growth is increasingly evident," CEO Jim Pr...n sales during the quarter,produced new business e...

...,Berryhill will be a distinguished keynote speaker... at Saddleback Church in Lake Forest, California.,... Coalition of Pastors,Spouses (NCPS), a nonpartisa...l recently addressed 150 of the top African Americ...

...cancers subvert the growth-control machinery in a ...study, at least one virus uses mimicry to gain acc... is a cell protein called the retinoblastoma prote...e retina, this tumor suppressor protein has since ...

South Florida HIE Phase II Completed and Phase III Awarded Announcing Always Best Care Senior Services Expansion into Colorado Springs, Colorado Photo: New York Goes Orange for Pumpkin Festival and Lupus Awareness Month Conseco Reports Third Quarter Results Head of Pastors' Spouses to Challenge Women at Saddleback's Global Summit on AIDS and the Church How one virus uses mimicry to replicate successfully

(Date:12/1/2009)...PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE ...t licensed to Chrono Nutraceuticals LLC exclusive ...nded release dietary supplements using SCOLR,s pro...ition, SCOLR granted Chrono rights to manufacture ... on a nonexclusive basis. Chrono paid SCOLR $25,0...

(Date:12/1/2009)...1 nContact Surgical, Inc. ("nConta... minimally-invasive treatment for heart conditions...clinical trial designed to evaluate the safety and...edure, the convergent procedure, for the treatment...). This prospective, feasibility study will enrol...

(Date:12/1/2009)...1 Siemens Hearing Instruments, In...l manufacturer of hearing instruments, announced i...al,s Sound Beginnings program. The alliance will b...of the renewed partnership, Siemens is expanding t...g instruments to both children and young adults, a...

Breaking Medicine Technology:SCOLR Pharma, Inc. Licenses Dietary Supplements 2 SCOLR Pharma, Inc. Licenses Dietary Supplements 3 nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 2 Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 2 Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 3 Bart Peterson to Join Lilly Leadership Team 48032 1 Bart Peterson to Join Lilly Leadership Team 48032 2 Bart Peterson to Join Lilly Leadership Team 48032 3 Low T Specialist reNEW MAN Promotes National Network of Doctors 48028 1 Low T Specialist reNEW MAN Promotes National Network of Doctors 48028 2 Low T Specialist reNEW MAN Promotes National Network of Doctors 48028 3 Low T Specialist reNEW MAN Promotes National Network of Doctors 48028 4 iPod Repair Site Eases Scam Worries with Unexpected Announcements 48023 1 iPod Repair Site Eases Scam Worries with Unexpected Announcements 48023 2 iPod Repair Site Eases Scam Worries with Unexpected Announcements 48023 3

[0] SCOLR Pharma, Inc. Licenses Dietary Supplements [0] nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure [0] Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need

...merican Society of Clinical ... Medarex, Inc.,(Nasdaq: MEDX ) today announced u...S) results from a Phase 2 clinical study (MDX010-0...carbazine (DTIC) where 11.4%, or 4 of,35 patients,...llow-up. This,included 1 patient that experienced ...

...with Other Targeted Therapies and as Monother...irst Phase II data investigating the dual inhibiti... molecule tyrosine-kinase inhibitors (TYKERB, and...R2 (ErbB2) positive bre... and AVASTIN(R) (bevacizumab), a, monoclonal antib...

Other Medicine Technology:Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 2 Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 3 Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 4 New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 2 New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 3 New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 4 New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 5 New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 6 New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 7 New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 8 New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 9 New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 10

Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens

...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...

Medicine Products:

Bretylol Bretylium, Serum or Plasma Brain Type Natriuretic Peptide Branched chain Amino Acids

NuVasive Prices $200 Million Convertible Senior Note...( SAN DIEGO March 4 /- NuVasive Inc...),Health